Oncology & Cancer

Novel radiotracer meets gold standard for imaging prostate cancer

The novel radiopharmaceutical 18F-PSMA-1007 is both effective and readily available for detecting malignant prostate cancer lesions, according to research published in the April issue of The Journal of Nuclear Medicine. With ...

Oncology & Cancer

Radiotherapy for prostate cancer adjusted during COVID-19

(HealthDay)—In a special article published online April 1 in Advances in Radiation Oncology, a framework is laid out for the management of radiotherapy for prostate cancer patients during the coronavirus disease 2019 (COVID-19) ...

page 15 from 30